Ustekinumab treatment in a patient with psoriasis and systemic lupus erythematosus

  • I-T Chyuan, T-H Tsai, T-H Chang, C-S Wu
  • Lupus, November 2014, SAGE Publications
  • DOI: 10.1177/0961203314561072

IL12/IL23 blockade in SLE: a case study

Why is it important?

There are unmet needs in the treatment of SLE. IL-23 blockade has some positive effects in the mice model of lupus nephritis.

Perspectives

Dr Chien-Sheng Wu
Far Eastern Memorial Hospital

SLE is used to be viewed as a B cell-mediated autoimmune disease. However, the success of rituximab in AAV in contrast to SLE implies that we have to rethink our hypothesis about the pathogenesis of SLE.

Read Publication

http://dx.doi.org/10.1177/0961203314561072

The following have contributed to this page: Dr Chien-Sheng Wu